(Bloomberg) -- Illumina Inc.’s blocked $7 billion takeover of cancer-detection provider Grail Inc. should never have been probed by the European Union, according to a top court ruling that ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Grail, which makes a blood test for cancer, said a vendor’s software issue caused inaccurate letters to be sent to about 400 customers last month. Shareholders are set to vote on Thursday ...

Whether millions of people will be able to afford one of the hot new weight-loss drugs could hinge on whether they cure the ...

Despite the planet’s growing plastic pollution crisis, petroleum-based polymers have become an integral part of modern life. They make cars and airplanes lighter and more energy efficient. They ...

Nearly four years after first pitching for Grail Inc. (NASDAQ:GRAL), Illumina Inc. (NASDAQ:ILMN) announced Monday that it ...

Illumina, which founded Grail and spun it off in 2016 only to re-acquire it in 2021 for $7.1 billion, had fought against the European Commission's decision to wield a rarely-used power called ...

A SAVVY shopper revealed her holy grail haircare buys that can be found at Sephora. For $30, beauty fans can snag a trial set that contains four different products to improve your locks even when ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." If I could do only one post-workout recovery activity for the rest of my life I'd choose foam rolling.

In a case that had been closely watched across multiple industries, Illumina chose to divest Grail in the light of legal action from the European Commission and the US Federal Trade Commission.

GRAIL said on Tuesday (Aug 13) it has cut about 350 existing jobs as the diagnostics company focuses on the development of its flagship cancer-detection test Galleri, sending its shares up more than ...

Antitrust regulators in Brussels had probed the acquisition despite Grail having no revenues or presence in the EU, usually a requirement for transactions to be investigated, and ultimately forced ...